Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...
President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...
Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
Ozempic is approved by the U.S. Food and Drug Administration to treat Type 2 ... "As a general matter of policy, the law directs CMS to use data that is aggregated across different dosage, forms ...
these products are not considered generic versions and are not approved by the Food and Drug Administration. The first round of Medicare negotiations yielded discounts on drugs ranging from 40 ...